Skip to main content
OpenTrials

Clinical trial condition

Progressive Supranuclear Palsy

Explore clinical trials studying Progressive Supranuclear Palsy. Study availability and eligibility vary by location and protocol.

91 public trials 18 recruiting studies
Refine in advanced search Browse all conditions

Progressive Supranuclear Palsy trial results

Active, not recruiting

A Study to Assess the Efficacy, Safety, and Pharmacokinetics of FNP-223 to Slow Progression of Progressive Supranuclear Palsy (PSP)

NCT06355531

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +17 more
Locations
  • The Neurology Center of Southern California - Carlsbad Carlsbad, California, United States
  • UCSF Weill Institute for Neurosciences San Francisco, California, United States
  • Rocky Mountain Movement Disorders Center Denver, Colorado, United States
  • University of Miami Miller School of Medicine Miami, Florida, United States
View all 44 locations
View Trial Details
Completed

Trial of Valproic Acid in Patients With Progressive Supranuclear Palsy (Depakine)

NCT00385710

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +14 more
Locations
  • Service de Neurologie A, Hôpital Gabriel Montpied-BP Clermont-Ferrand, France
  • Service de Neurologie et Pathologie du mouvement Hôpital Roger Salingro, CHRU de Lille Lille, France
  • Service de Neurologie, CHU Nantes Nantes, France
  • Service de Neurologie, CHU Poitiers Poitiers, France
View Trial Details
Completed

Trial of Parkinson's And Zoledronic Acid

NCT03924414

Conditions
Atypical Parkinsonism, Autonomic Nervous System Diseases, Basal Ganglia Diseases, +37 more
Locations
  • Mayo Clinic Scottsdale, Arizona, United States
  • Washington Regional Medical Center Fayetteville, Arkansas, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Sutter Health Berkeley, California, United States
View all 77 locations
View Trial Details
Completed

Research of Biomarkers in Parkinson Disease

NCT00465790

Conditions
Autonomic Nervous System Diseases, Basal Ganglia Diseases, Brain Diseases, +34 more
Locations
  • Meditterranean Institute for Life Sciences Split, Croatia
  • INSERM Unit 679 Paris, France
  • University of Lübeck and Neuroimage Nord Lübeck, Germany
  • University Hospital Tübingen Tübingen, Germany
View Trial Details
Completed

AMX0035 and Progressive Supranuclear Palsy

NCT06122662

Conditions
Atypical Parkinsonism, Basal Ganglia Diseases, Brain Diseases, +16 more
Locations
  • Mayo Clinic Scottsdale, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Parkinson's & Movement Disorder Institute Fountain Valley, California, United States
  • University of Southern California Los Angeles, California, United States
View all 62 locations
View Trial Details
Completed

A Phase 2a Study of TPN-101 in Patients With Progressive Supranuclear Palsy (PSP)

NCT04993768

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +14 more
Locations
  • St. Joseph's Hospital and Medical Center, Barrow Neurological Institute Phoenix, Arizona, United States
  • UC San Diego Altman Clinical And Translational Research Institute La Jolla, California, United States
  • UCSF Neurosciences Clinical Research Unit (NCRU) San Francisco, California, United States
  • Rocky Mountain Movement Disorders Center Englewood, Colorado, United States
View all 14 locations
View Trial Details
Completed

GV1001 Subcutaneous(SC) for the Treatment of Progressive Supranuclear Palsy (PSP)

NCT05819658

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +14 more
Locations
  • Seoul National University Bundang Hospital Seongnam-si, South Korea
  • Kyung Hee University Hospital Seoul, South Korea
  • Samsung Medical Center Seoul, South Korea
  • Seoul Metropolitan Government Seoul National University Boramae Medical Center Seoul, South Korea
View Trial Details
Completed

Administration of GV1001 for the Treatment of Progressive Supranuclear Palsy Who Completed Study GV1001-PSP-CL2-011

NCT06235775

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +14 more
Locations
  • Seoul National University Bundang Hospital Seongnam-si, South Korea
  • Kyung Hee University Hospital Seoul, South Korea
  • Samsung Medical Center Seoul, South Korea
  • Seoul Metropolitan Government Seoul National University Boramae Medical Center Seoul, South Korea
View Trial Details

Related conditions